Results 191 to 200 of about 311,268 (263)

Determinants of natural killer cell-mediated antibody dependent cellular cytotoxicity in SARS-CoV-2 antibodies. [PDF]

PLoS Pathog
Depierreux DM, Ruiz F, Lilly M, Guenthoer J, Chohan V, Overbaugh J.   +5 more
europepmc   +1 more source

The use of tacrolimus (FK506) and antimetabolites as immunosuppressants for xenotransplantation across closely related rodent species [PDF]

, 1997
Demetris, AJ, Fung, JJ, Murase, N, Rao, AS, Starzl, TE, Valdivia, LA   +5 more
core  

RGX-019-MMAE inhibits leukemia progression by targeting MER proto-oncogene tyrosine kinase (MERTK) in acute myeloid leukemia. [PDF]

J Exp Clin Cancer Res
Tyagi A, Siddiqui M, Eckstrom A, Kurth I, Takeda S, Sharma P, Borthakur G, Yuan B, Abbas HA, Anand V, Borgman J, Kornblau S, Maiti A, Battula VL.   +13 more
europepmc   +1 more source

An Immunomodulating Peptide With Potential to Counteract Endometriosis. [PDF]

Aust N Z J Obstet Gynaecol
Agrez M.
europepmc   +1 more source

Tailored strategies for improved control of CAR-T cells in multiple myeloma. [PDF]

Front Immunol
Bielowski A, Kilian T, Vera-Cruz S, Deveuve Q, Kraus S, Einsele H, Hudecek M, Danhof S.   +7 more
europepmc   +1 more source

Therapeutic Antibodies in Hematology: Advances in Malignant and Non-Malignant Disorders. [PDF]

Cells
Yasui H, Idogawa M, Ishida T, Imai K.
europepmc   +1 more source

Predictive value of natural killer (NK) cells in bone marrow for relapse in diffuse large B cell lymphoma: integrating antibody-dependent cell-mediated cytotoxicity (ADCC)-based immunotherapy. [PDF]

Cancer Immunol Immunother
Rincón-López S, Atencio-Matos J, Pereda-Sainz O, Larreina-Pérez J, Campeny-Najara A, Esteban-Figuerola A, Hernandez-Perez M, Garrastachu-Zumaran P, Velasco-Ruiz M, García-Bosque I, Rodriguez-Lefler C, Ruiz de Gaona E, Feliu J, Cabello J, Martín-Carnicero A, García-Muñoz R.   +15 more
europepmc   +1 more source

Antibody-dependent cell-mediated cytotoxicity (ADCC)in liver diseases

Kanzo, 1980
openaire   +4 more sources